Streetbeat News

Products Services

AKBA

Akebia Therapeutics has received FDA approval for its Vafseo tablets, a once-daily oral HIF-PH inhibitor designed to treat dialysis-related anemia. The company has developed a launch strategy aiming to establish Vafseo as a new oral standard of care for this condition.

Portfolio Pulse from Benzinga Newsdesk

March 28, 2024 | 5:51 am

TSLA

Wedbush analyst Daniel Ives maintains an Outperform rating on Tesla (TSLA) but cuts the price target from $315 to $300 ahead of Q1 deliveries update. Citing demand and supply issues, including soft demand in China and production challenges, Ives reduces Q1 delivery estimates from 475,000 to 425,000 units. Despite short-term challenges, Ives remains bullish on Tesla's long-term prospects, emphasizing the importance of Tesla's Full Self-Driving (FSD)/autopilot strategy.

Portfolio Pulse from Shanthi Rexaline

March 28, 2024 | 5:42 am

TTWO

Take-Two Interactive Software has agreed to acquire The Gearbox Entertainment Company for $460 million, with the transaction expected to close in the first quarter of Take-Two's Fiscal Year 2025. This acquisition will expand 2K's internal development team by adding Gearbox's industry-leading talent. Additionally, Gearbox and 2K are currently developing the next installment in the Borderlands series.

Portfolio Pulse from Benzinga Newsdesk

March 28, 2024 | 5:36 am

FSR

Fisker Inc. faced significant operational challenges, including the loss of millions in customer payments due to lax procedures, leading to an internal audit and resource diversion. The company recovered most payments but experienced delays in processing funds and filing its annual financial report for 2023. Fisker announced major price cuts for its 2023 Ocean SUV models amid financial struggles, including a recent delisting from the NYSE and failed investment talks. The company's cash balance significantly decreased, and it reported a substantial net loss for Q4. Despite production efforts, Fisker has a large inventory and initiated a production pause to address issues.

Portfolio Pulse from Anan Ashraf

March 28, 2024 | 5:28 am

NKLA

Nikola Corp, in collaboration with Blackjacks Roadhouse and others, unveiled Alberta's first commercial hydrogen fueling station, marking a significant step in developing hydrogen fuel infrastructure. The HYLA station is located in a high-traffic area and is part of Nikola's broader strategy to scale hydrogen-powered vehicles. Despite delivering 35 hydrogen FCEVs in Q4 and producing 138 trucks last year, Nikola reported a gross loss of $214.1 million for the period. The company's shares rose 11.7% following the announcement.

Portfolio Pulse from Anan Ashraf

March 28, 2024 | 4:03 am

TSLA

Elon Musk, CEO of Tesla and SpaceX, criticized Quora for its pretentiousness on his social media platform X, responding to a user's rant about the site. This interaction highlights Musk's active engagement on social media and adds a personal layer due to his ex-wife's history with Quora.

Portfolio Pulse from Benzinga Neuro

March 28, 2024 | 3:34 am

MU

NVDA

SSNLF

Goldman Sachs predicts significant growth in the high-bandwidth memory (HBM) chip market, driven by demand for Nvidia's new Blackwell GPU chips. The market is expected to grow tenfold to $23 billion by 2026. SK Hynix, Samsung Electronics, and Micron Technology are identified as primary beneficiaries. This growth comes amid heightened interest in AI, with Nvidia's stock rising due to the AI boom sparked by OpenAI's ChatGPT.

Portfolio Pulse from Benzinga Neuro

March 28, 2024 | 1:58 am

MDXXF

PharmAla Biotech Holdings (OTC:MDXXF) has been granted a US patent for ALA-002, a novel MDMA mixture, by the USPTO. This patent covers the composition of ALA-002, a mixture of MDMA enantiomers aimed at reducing adverse effects and addiction potential while improving pro-social effects. The company plans to pursue clinical research for treating social anxiety in Autism Spectrum Disorder and other neurological disorders, leveraging this patent to accelerate global IP efforts.

Portfolio Pulse from Lara Goldstein

March 27, 2024 | 10:56 pm

BCAN

Cannasoft Enterprises (NASDAQ:BCAN) has announced the suspension of their medical cannabis facility construction to pivot towards the Femtech sector, citing negative shifts in the global medical cannabis market and security concerns due to its proximity to the Gaza border. The company, known for its CRM software for the cannabis industry, plans to expand into the rapidly growing Femtech sector, leveraging its experience in software and manufacturing, including the development of the EZ-G Device, a CBD Oil sex toy.

Portfolio Pulse from Rolando García

March 27, 2024 | 10:27 pm

AUMN

CLF

FCX

FMST

GOLD

Foremost Lithium Resource & Technology (FMST) reports significant drilling progress in Manitoba, aiming for an updated resource estimate. Barrick Gold (GOLD) exits the El Quevar silver project agreement with Golden Minerals (AUMN), effective April 20, 2024. Cleveland-Cliffs (CLF) increases steel prices by $60 per net ton. Freeport-McMoRan (FCX) announces a 15-cents-per-share dividend, payable on May 1, 2024.

Portfolio Pulse from Austin DeNoce

March 27, 2024 | 9:46 pm